Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy

Abstract

High copayment for SPC therapy was associated with significantly worse persistence among hypertensive patients. Persistence was associated with substantially lower frequencies of hospitalizations and ER visits and net healthcare cost savings.